Obesity Featured Articles

  1. Resensitizing Treatment-Resistant Cancer Holds Promise Over Replacing Once-Efficacious Therapies 9/21/2026

    John Yu, MD, of Kairos Pharma, explains why reversing treatment resistance could extend the life of proven cancer therapies and improve patient outcomes.

  2. AI, Open Source, & the Future of Biostatistics 9/18/2026

    AI and open-source tools are changing statistical programming. Learn how to validate, govern, and apply them without sacrificing the accuracy and oversight clinical research demands.

  3. Why Oncology Programs Can't Rely On An Inside View Alone 9/18/2026

    Discover how looking outside a program can help oncology teams test assumptions, improve feasibility, and make stronger development decisions.

  4. In Case You Missed Them: Recapping The FDA's Recent Guidances For Cell And Gene Therapies 9/17/2026

    I review 10 of the FDA’s guidances spanning the last 12 months, all of which aid cell and gene therapy companies to assure safety and efficacy of these medicines.

  5. Repurposing Three FDA-Approved Drugs For A New Stroke Recovery Strategy 9/17/2026

    When three drugs become one — the polypharmacology strategy, 505(b)(2) pathway, and objective endpoints Nuero-Innovators is relying on to bring new hope to stroke patients.

  6. Before Adding AI, Fix The Process 9/17/2026

    Regeneron’s Kaniel Cassady argues that “doing more with less” in clinical development should start with questioning existing processes, unnecessary data collection, and outdated workflows before turning to AI and other new technologies.

  7. What Is eCOA In Clinical Trials? A Strategic Enabler For Participant Engagement And Data Integrity 9/16/2026

    Replacing paper questionnaires with digital assessments helps trial teams capture consistent, real-time participant data and reduce missing entries.

  8. Déjà vu? A Decade At AAIC, And The Endpoints Haven't Moved 9/16/2026

    Cognitive endpoints in Alzheimer's trials haven't kept pace with the shift to earlier-stage treatment. Modern trials need tools built to catch subtle change.

  9. Coalition Takes Guesswork Out Of Charcot-Marie-Tooth Disease Research With New Guidance 9/16/2026

    A new Charcot-Marie-Tooth guidance introduces practical recommendations to help sponsors design clearer, more patient-centered, regulator-ready trials.

  10. CTIS Results In The Spotlight 9/15/2026

    A new study finds fewer than half of EU Clinical Trial Information System (CTIS) trials met results reporting requirements. The EMA is now watching more closely. Here’s what sponsors need to know.